NIAID Site Search

Lenette Lu, M.D., Ph.D., of the Massachusetts General Hospital K08 sample application

Last Reviewed: March 31, 2025

Stella Kakeeto, M.B.A., Makerere University G11 sample application

Last Reviewed: March 31, 2025

This document provides an overview of research and training programs opportunities for 2019-2020 available through the Division of Intramural Research.

Last Reviewed: May 21, 2021

This document describes the purpose of Tuberculosis Research Unit and how it integrates scientific and clinical research disciplines.

Last Reviewed: December 2, 2019

Generic Preclinical Development Plan for Human Monoclonal Antibodies

Last Reviewed: August 1, 2024

Once scientists identify and test potential targets and approaches to vector control in the laboratory, research typically moves from the basic stage into translational and then clinical research phases. These later stages of research may include field testing of new or improved products and techniques as well as performing clinical trials. Translational Research Once targets—such as specific

Last Reviewed: September 6, 2022

This document outlines systematic evaluation of nine monogenic autoinflammatory diseases.

Last Reviewed: April 7, 2021

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

A team of NIAID-led researchers has identified a mechanism in mice in which the immune system and commensal bacteria help repair damaged sensory neurons within the skin. They hope their findings could lead to therapies that stimulate recovery in people following skin injury and limit damage from chemotherapy and chronic diseases.

Published: January 18, 2023

Product Development Plan (PDP) for a Generic Prophylactic Vaccine for Infectious Diseases

Last Reviewed: September 30, 2023

NIAID conducts and supports research to understand how influenza strains emerge, evolve, infect and cause disease (called pathogenesis) in animals and humans.

Last Reviewed: March 13, 2017

This WORD document provides a tool for evaluating organization review, coordinate and maintain oversight of all applications and proposal

Last Reviewed: August 6, 2019

Last Reviewed: March 28, 2024

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Sample application from Nicole Putnam, Ph.D., for National Research Service Award (NRSA) individual fellowship (F31) grants.

Last Reviewed: January 25, 2023

Here NIH offers information to help you determine whether your research is considered human subjects and how to comply with regulations at all phases.

Last Reviewed: November 18, 2024

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Incorporating Systems Biology to Vector-Borne Pathogen Research: Current Landscape, Challenges, and Opportunities

Last Reviewed: November 4, 2022

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

Scientists have long been aware that malaria infection is associated with high levels of autoantibodies—antibodies that recognize and attack the person’s own tissues and are associated with autoimmune disorders. NIAID researchers, along with their colleagues, have studied the molecular mechanisms of these autoantibodies. Their findings reveal the associations between malaria, human resistance to it, and autoantibodies that are linked to certain autoimmune disorders—specifically, systemic lupus erythematosus (SLE).

Published: July 5, 2024

Lead Institution: University of California, Irvine, USA ICEMR website: https://www.icemreastafrica.org/ Research Areas The overall goal of this project is to assess the impact of Anopheles stephensi invasion and spread on malaria epidemiology and transmission, develop efficient tools and methods for surveillance of An. stephensi, and identify cost-effective vector control methods that can be

Last Reviewed: July 12, 2024

Jordan Report: Accelerated Development of Vaccines (2012) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2012

Expert articles from Jordan Report: Accelerated Development of Vaccines (2012) from NIAID

Last Reviewed: December 31, 2012

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: October 10, 2023

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with

Published: June 25, 2019